Managing puerperium in patients with systemic autoimmune diseases: an update.
Autoimmune rheumatic diseases
breastfeeding
chronic arthritis
disease activity
post-partum complications
postpartum depression
puerperium
women’s health
Journal
Expert review of clinical immunology
ISSN: 1744-8409
Titre abrégé: Expert Rev Clin Immunol
Pays: England
ID NLM: 101271248
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
pubmed:
9
3
2022
medline:
5
4
2022
entrez:
8
3
2022
Statut:
ppublish
Résumé
Puerperium is a critical period for patients affected by autoimmune rheumatic diseases for the risk of disease's flares and difficulties in treating lactating mothers. We want to summarize the literature data about psychological and pharmacological management of these patients and possible risk factors of disease's flares. We made a narrative review on recent studies about puerperium in rheumatic autoimmune diseases patients. The physicians involved in management of patients during puerperium and in the follow-up of babies need to agree on maternal treatment because they need to reassure mothers about the safety of the prescribed medications. Furthermore, women with rheumatic diseases could present some musculoskeletal limitations and psychological problems, such as postpartum depression, which can lead to a sense of inadequacy to the mother's task. Families and physicians should be aware of these possible complications and support the new mothers providing correct counseling and practical help.
Identifiants
pubmed: 35255770
doi: 10.1080/1744666X.2022.2050216
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM